{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T13:39:21Z","timestamp":1744724361747},"reference-count":1,"publisher":"S.C. JURNALUL PENTRU MEDICINA SI VIATA S.R.L","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMedLife"],"DOI":"10.25122\/jml-2024-1004","type":"journal-article","created":{"date-parts":[[2024,8,19]],"date-time":"2024-08-19T09:41:52Z","timestamp":1724060512000},"page":"243-243","source":"Crossref","is-referenced-by-count":1,"title":["A positive effect of Cerebrolysin on motor functions and spasticity in ALS with limb or bulbar onset is questionable"],"prefix":"10.25122","volume":"17","author":[{"given":"Alfredo Jos\u00e9","family":"Firstenfeld","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Servicio de Neurociencias, Universidad de Buenos Aires, Instituto Cardiol\u00f3gico Banfield, Buenos Aires, Argentina","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10755","published-online":{"date-parts":[[2024,2]]},"reference":[{"issue":"12","key":"ref1","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.25122\/jml-2023-0459","article-title":"Add-on treatment with Cerebrolysin improves clinical symptoms in patients with ALS: results from a prospective, single-center, placebo-controlled, randomized, double-blind, phase II study","volume":"16","author":"Firstenfeld AJ, Listorti J, Jalaff N, Loaiza Orozco CP","year":"2023","unstructured":"1. Firstenfeld AJ, Listorti J, Jalaff N, Loaiza Orozco CP, Add-on treatment with Cerebrolysin improves clinical symptoms in patients with ALS: results from a prospective, single-center, placebo-controlled, randomized, double-blind, phase II study, J Med Life, 2023;16(12):1750-55","journal-title":"J Med Life"}],"container-title":["Journal of Medicine and Life"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/medandlife.org\/all-issues\/2024\/issue-2-2024\/response-to-the-letter-to-the-editor-issue-2-2024\/a-positive-effect-of-cerebrolysin-on-motor-functions-and-spasticity-in-als-with-limb-or-bulbar-onset-is-questionable-2\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,19]],"date-time":"2024-08-19T09:43:30Z","timestamp":1724060610000},"score":1,"resource":{"primary":{"URL":"https:\/\/medandlife.org\/all-issues\/2024\/issue-2-2024\/response-to-the-letter-to-the-editor-issue-2-2024\/a-positive-effect-of-cerebrolysin-on-motor-functions-and-spasticity-in-als-with-limb-or-bulbar-onset-is-questionable-2\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":1,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["JMedLife-17-243"],"URL":"https:\/\/doi.org\/10.25122\/jml-2024-1004","relation":{},"ISSN":["1844-3117"],"issn-type":[{"value":"1844-3117","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2]]}}}